AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:08 2024-04-25 am EDT			5-day change	1st Jan Change
12,026 ^GBX	+5.94%		+10.19%	+13.45%

06:54pm	Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump	MT
06:02pm	ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

ASTRAZENECA : Barclays reaffirms its Buy rating

January 22, 2021 at 07:11 am EST

In a research note published by Emily Field, Barclays advises its customers to buy the stock. The target price is reduced from GBX 9300 to GBX 9000.

Latest news about AstraZeneca PLC

Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump	12:54pm	MT
ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade	12:02pm
FTSE 100 shakes off red-hot US inflation gauge	11:58am	AN
Global markets live: Ford, Dow, American Airlines, Comcast, Apple, IBM, Cisco...	11:43am
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	11:11am	MT
ASTRAZENECA : UBS maintains a Sell rating	09:40am	ZD
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	09:22am	MT
The specter of stagflation rears its ugly head again	09:21am
Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15	09:20am	DP
Sector Update: Health Care	08:55am	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	08:33am	MT
ASTRAZENECA : Jefferies sticks Neutral	08:25am	ZD
ASTRAZENECA : JP Morgan remains its Buy rating	08:15am	ZD
FTSE 100 hits high on offer for Anglo American	06:52am	AN
Transcript : AstraZeneca PLC, Q1 2024 Earnings Call, Apr 25, 2024	06:45am
AstraZeneca Q1 Core Earnings, Revenue Increase -- Shares Jump Premarket	06:31am	MT
ANALYST RECOMMENDATIONS : Meta Platforms, UPS, Boeing, Chipotle, Dell Technologies...	05:58am
AstraZeneca Earnings, Sales Rise, Beating Forecasts -- Update	05:43am	DJ
European Midday Briefing : Mood Cautious Ahead of More U.S Tech, Key Data	05:20am	DJ
London rises ahead of US GDP data	04:56am
AstraZeneca: strong sales growth in Q1	04:34am	CF
AstraZeneca upbeat as cancer drugs underpin sales growth	04:20am	AN
Anglo American jumps on takeover bid from BHP	04:14am	AN
FTSE 100 hits record high on big mining M&A, earnings push	03:24am	RE
Miner Anglo American reviews takeover bid from rival BHP	02:58am	AN

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

Pharmaceuticals

Calendar

02:00am - Q1 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT

More Strategies

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

141.1 USD

Average target price

161.4 USD

Spread / Average Target

+14.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASTRAZENECA PLC	+13.45%	219B
NOVO NORDISK A/S	+24.17%	562B
JOHNSON & JOHNSON	-6.48%	358B
MERCK & CO., INC.	+19.70%	322B
ABBVIE INC.	+7.96%	297B
NOVARTIS AG	+6.04%	199B
ROCHE HOLDING AG	-10.51%	196B
PFIZER, INC.	-11.74%	149B
AMGEN INC.	-6.66%	146B
SANOFI	+2.07%	117B

Other Pharmaceuticals

AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

ASTRAZENECA : Barclays reaffirms its Buy rating

Latest news about AstraZeneca PLC

Chart AstraZeneca PLC

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for AstraZeneca PLC

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals